Nurix Therapeutics, Inc. (NRIX)

Typically moves ±5.80% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-10-09 APPROXIMATE

Across 24 earnings reports since Oct 14, 2020, Nurix Therapeutics, Inc. (NRIX) has a clear post-earnings pattern. It moves ±5.80% on average after reporting and finishes higher 54.2% of the time. Its largest post-earnings gain was +20.63% (Apr 13, 2023) and its largest decline was -10.24% (Apr 10, 2024). The next earnings report is predicted for 2026-10-09 (approximate).

Earnings reactions

How NRIX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±5.80%

Positive %

54.2%

Negative %

45.8%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Jul 09, 2026	☽ POST	-6.56%	open_in_new
Apr 08, 2026	☀ PRE	-4.59%	open_in_new
Jan 28, 2026	☽ POST	-1.57%	open_in_new
Oct 09, 2025	☽ POST	-10.13%	open_in_new
Jul 09, 2025	☽ POST	-3.87%	open_in_new
Apr 08, 2025	☽ POST	+3.67%	open_in_new
Jan 28, 2025	☽ POST	+0.46%	open_in_new
Oct 11, 2024	☽ POST	+6.47%	open_in_new
Jul 11, 2024	☽ POST	+8.13%	open_in_new
Apr 10, 2024	☀ PRE	-10.24%	open_in_new
Feb 15, 2024	☽ POST	+0.2%	open_in_new
Oct 12, 2023	☽ POST	+2.25%	open_in_new
Jul 13, 2023	☽ POST	-3.17%	open_in_new
Apr 13, 2023	☽ POST	+20.63%	open_in_new
Feb 09, 2023	☽ POST	+3.74%	open_in_new
Oct 06, 2022	☽ POST	-7.19%	open_in_new
Jul 07, 2022	☽ POST	+14.48%	open_in_new
Apr 07, 2022	☽ POST	+11.76%	open_in_new
Jan 27, 2022	☽ POST	+2.14%	open_in_new
Oct 14, 2021	☽ POST	+1.16%	open_in_new
Jul 13, 2021	☽ POST	-2.24%	open_in_new
Apr 13, 2021	☽ POST	+12.91%	open_in_new
Feb 16, 2021	☽ POST	-0.4%	open_in_new
Oct 14, 2020	☽ POST	-1.18%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.80%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 24 →

Funds holding

$572010026

Total value held

Buying

16 added · 8 reduced

Blackrock, Inc.

$212768666 -1.74%

Morgan Stanley

$115537879 -3.44%

State Street Corp

$113469939 -9.02%

Ubs Group Ag

$22249259 NEW BUY

Northern Trust Corp

$21253458 +2.53%

SEC Filing Types

description SCHEDULE 13G/A

16 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
144	20260902	open_in_new SEC.gov
4	20260902	open_in_new SEC.gov
4	20260901	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G	20260814	open_in_new SEC.gov
SCHEDULE 13G	20260814	open_in_new SEC.gov
144	20260805	open_in_new SEC.gov
4	20260805	open_in_new SEC.gov

Frequently asked about NRIX earnings

When does Nurix Therapeutics, Inc. report earnings next? expand_more

Nurix Therapeutics, Inc. (NRIX)'s next earnings date is approximate for 2026-10-09. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does NRIX stock move after earnings? expand_more

Over 24 reports, NRIX has moved an average of ±5.80% the session after earnings, closing higher 54.2% of the time.

What was NRIX's biggest post-earnings move? expand_more

NRIX's largest post-earnings gain on record was +20.63% on Apr 13, 2023, and its largest decline was -10.24% on Apr 10, 2024.

Where can I find Nurix Therapeutics, Inc.'s SEC filings? expand_more

All of Nurix Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.